Stable Growth and Positive Outlook: A Buy Recommendation for Medtronic

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.

Josh Jennings has given his Buy rating due to a combination of factors surrounding Medtronic’s financial performance and market position. Jennings anticipates that the company will report fourth-quarter earnings that align with current expectations, suggesting a stable and predictable financial outlook. The forecasted revenue growth of 4-5% is considered durable, indicating a steady climb in Medtronic’s business operations and signifying confidence in the company’s future. Furthermore, Medtronic’s earnings per share (EPS) estimate, though at the higher end of the guidance range, is viewed as realistic given the firm’s transparent communication regarding the challenges it faces, which may curtail any negative surprises regarding potential lower EPS figures.

Moreover, Jennings’ analysis points out that Medtronic’s projected organic revenue growth demonstrates an acceleration from previous quarters, underscoring the company’s robust performance relative to its competitors. He highlights the conservative nature of his revenue projections, which are slightly below the Street’s estimates, and yet believes they are prudent given the strong sales growth rates reported by Medtronic’s peers. This conservative approach to revenue estimation, coupled with an EPS forecast that sits comfortably within the company’s guidance range, suggests a cautious yet optimistic view of Medtronic’s financial health, reinforcing the Buy recommendation. Jennings’ report reflects a thorough examination of Medtronic’s financials, competitive positioning, and market trends, leading to a positive outlook on the stock.

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

Medtronic (MDT) Company Description:

Founded in 1949, Medtronic Plc, a medical technology company, develops, manufactures, distributes, and sells device-based medical therapies and services worldwide. It operates through four segments, including Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The company is headquartered in Dublin, Ireland.